Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 386074, 3 pages
http://dx.doi.org/10.1155/2013/386074
Clinical Study

Pharmacodynamic Effect of Clopidogrel in Patients Undergoing Transcatheter Aortic Valve Implantation

Third Faculty of Medicine, Charles University, University Hospital Vinohrady, Cardiocenter, Srobarova 50, 100 34 Prague 10, Czech Republic

Received 12 April 2013; Accepted 25 June 2013

Academic Editor: Namal Wijesinghe

Copyright © 2013 Petr Tousek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • V. J. Nijenhuis, N. Bennaghmouch, J.-P. van Kuijk, D. Capodanno, and J. M. ten Berg, “Antithrombotic treatment in patients undergoing transcatheter aortic valve implantation (TAVI),” Thrombosis and Haemostasis, vol. 113, no. 4, 2015. View at Publisher · View at Google Scholar
  • Katia Orvin, Alon Eisen, Leor Perl, Noa Zemer-Wassercug, Pablo Codner, Abid Assali, Hana Vaknin-Assa, Eli I. Lev, and Ran Kornowski, “Platelet reactivity in patients undergoing transcatheter aortic valve implantation,” Journal of Thrombosis and Thrombolysis, 2015. View at Publisher · View at Google Scholar
  • Katarzyna Czerwińska-Jelonkiewicz, Adam Witkowski, Maciej Dąbrowski, Walerian Piotrowski, Tomasz Hryniewiecki, and Janina Stępińska, “The role of platelet reactivity assessment in dual antiplatelet prophylaxis after transcatheter aortic valve implantation,” Archives of Cardiovascular Diseases, 2017. View at Publisher · View at Google Scholar
  • Stephan Windecker, Marco Valgimigli, George Dangas, Pascal Vranckx, Robert C Welsh, and Roxana Mehran, “Thrombo-embolic prevention after transcatheter aortic valve implantation,” European Heart Journal, vol. 38, no. 45, pp. 3341–3350, 2017. View at Publisher · View at Google Scholar
  • María Henar García-Lagunar, Luciano Consuegra-Sánchez, Pablo Conesa- Zamora, Javier Ruiz-Cosano, Federico Soria Arcos, Luis García De Guadiana, Pedro Cano Vivar, Juan Antonio Castillo-Moreno, and Antonio Melgarejo-Moreno, “Genotyping of six clopidogrel-metabolizing enzyme polymorphisms has a minor role in the assessment of platelet reactivity in patients with acute coronary syndrome,” Anatolian Journal of Cardiology, vol. 17, no. 4, pp. 303–312, 2017. View at Publisher · View at Google Scholar
  • Vincent Johan Nijenhuis, Jurrien Maria ten Berg, Christian Hengstenberg, Thierry Lefèvre, Stephan Windecker, David Hildick-Smith, Christian Kupatt, Eric Van Belle, Christophe Tron, Hans Ulrich Hink, Antonio Colombo, Bimmer Claessen, Samantha Sartori, Jaya Chandrasekhar, Roxana Mehran, Prodromos Anthopoulos, Efthymios N. Deliargyris, and George Dangas, “Usefulness of Clopidogrel Loading in Patients Undergoing Transcatheter Aortic Valve Implantation (From the BRAVO-3 Randomized Trial),” The American Journal of Cardiology, 2019. View at Publisher · View at Google Scholar
  • Thomas G. Nührenberg, Julia Hromek, Alexander Kille, Willibald Hochholzer, Manuel Hein, Dietmar Trenk, Franz-Josef Neumann, Christian Stratz, and Philipp Ruile, “Impact of On-Clopidogrel Platelet Reactivity on Incidence of Hypoattenuated Leaflet Thickening After Transcatheter Aortic Valve Replacement,” JACC: Cardiovascular Interventions, vol. 12, no. 1, pp. 12–18, 2019. View at Publisher · View at Google Scholar
  • Victor Alfonso Jimenez Diaz, Antonio Tello-Montoliu, Raul Moreno, Ignacio Cruz Gonzalez, Jose Antonio Baz Alonso, Rafael Romaguera, Eduardo Molina Navarro, Pablo Juan Salvadores, Emilio Paredes Galan, Antonio De Miguel Castro, Guillermo Bastos Fernandez, Alberto Ortiz Saez, Saleta Fernandez Barbeira, Sergio Raposeiras Roubin, Juan Ocampo Miguez, Antonio Serra Peñaranda, Mariano Valdes Chavarri, Angel Cequier Fillat, Francisco Calvo Iglesias, and Andres Iñiguez Romo, “Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement,” JACC: Cardiovascular Interventions, vol. 12, no. 1, pp. 22–32, 2019. View at Publisher · View at Google Scholar
  • Davide Capodanno, and Dominick J. Angiolillo, “Tailoring Antiplatelet Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement,” JACC: Cardiovascular Interventions, vol. 12, no. 1, pp. 33–37, 2019. View at Publisher · View at Google Scholar
  • Paul Guedeney, Roxana Mehran, Jean-Philippe Collet, Bimmer E. Claessen, Jurriën ten Berg, and George D. Dangas, “Antithrombotic Therapy After Transcatheter Aortic Valve Replacement,” Circulation: Cardiovascular Interventions, vol. 12, no. 1, 2019. View at Publisher · View at Google Scholar